Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
Medical Devices
Overview
Conditions
Intellectual Property
Research
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
E-Alerts
Signup to receive news and announcements from Nutra Pharma:
First Name:
Last Name:
Email:
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

Research

A Paraffin Baiting Technique that Enables a Direct Microscopic View of "in situ" Morphology of Nocardia asteroides with the Acid-Fast or Fluorescence Staining Procedures
 
 
Paraffin Slide Culture Technique for Isolating Non-Tuberculosis Mycobacteria from Stool and Sputum of HIV Sero Positivie Patients
 
 
Utilization of Paraffin Slide Culture Method for Antibiotic Sensitivity Testing of Non Tubercular Mycobacteria
 
 
Diagnosis of Opportunistic Infections in HIV/AIDS
 
 
Paraffin Slide Culture Technique for "Baiting" Non-Tuberculous Mycobacteria
 
 
The Adaption of Fluorescence Microscopy for Nocardia Asteroides: A Preliminary Report
 
Quick Nav
Nyloxin // Chronic Pain Relief
Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.
 

 

 
Recent News
 
March 14, 2017
Nutra Pharma CEO Rik Deitsch Interviewed by Stockguru.com


February 22, 2017
Global Small Caps Initiates Coverage on Nutra Pharma


February 15, 2017
Nutra Pharma and Nyloxin Featured on NBC News-Miami


 
 
Announcements
Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
 
 
Facebook   Twitter
 
NPC
Privacy Policy Code of Ethics